A VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR EXHIBITS ALTERED TYPE-ALPHA TRANSFORMING GROWTH-FACTOR BINDING AND TRANSMEMBRANE SIGNALING

被引:116
作者
MORIAI, T
KOBRIN, MS
HOPE, C
SPECK, L
KORC, M
机构
[1] UNIV CALIF IRVINE,DEPT MED,IRVINE,CA 92717
[2] UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717
关键词
PROTOONCOGENES;
D O I
10.1073/pnas.91.21.10217
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epidermal growth factor (EGF) and type alpha transforming growth factor (TGF-alpha) bind to a specific region in subdomain III of the extracellular portion of the EGF receptor (EGFR). Binding leads to receptor dimerization, auto- and transphosphorylation on intracellular tyrosine residues, and activation of signal transduction pathways. We compared the binding and biological actions of EGF and TGF-alpha in Chinese hamster ovary (CHO) cells expressing either wild-type human EGFR (HER497R) or a variant EGFR that has an arginine-to-lysine substitution in the extracellular domain at codon 497 (HER497K) within subdomain IV of EGFR. Both receptors exhibited two orders of binding sites with radioiodinated EGF (I-125-EGF). Similar results were obtained with I-125-TGF-alpha in cells expressing HER497R. In contrast, only one order of low-affinity binding sites was seen with I-125-TGF alpha in the case of HER497K. Although EGF and TGF-alpha enhanced tyrosine phosphorylation of both receptors, CHO cells expressing HER497K exhibited an attenuated growth response to EGF and TGF-alpha and a reduced induction of the protooncogenes FOS, JUN, and MYC. Moreover, high concentrations of TGF-alpha (5 nM) inhibited growth in these cells but not in cells expressing HER497R. These findings indicate that a region in subdomain IV of EGFR regulates signal transduction across the cell membrane and selectively modulates the binding characteristics of TGF-alpha.
引用
收藏
页码:10217 / 10221
页数:5
相关论文
共 25 条
[1]   MUTATIONS IN THE CAENORHABDITIS-ELEGANS LET-23 EGFR-LIKE GENE DEFINE ELEMENTS IMPORTANT FOR CELL-TYPE SPECIFICITY AND FUNCTION [J].
AROIAN, RV ;
LESA, GM ;
STERNBERG, PW .
EMBO JOURNAL, 1994, 13 (02) :360-366
[2]  
AVIVI A, 1991, ONCOGENE, V6, P673
[3]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[4]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[5]   SIGNAL TRANSMISSION BY THE INSULIN-LIKE GROWTH-FACTORS [J].
CZECH, MP .
CELL, 1989, 59 (02) :235-238
[6]  
GAN BS, 1987, J PHARMACOL EXP THER, V242, P331
[7]   EPIDERMAL GROWTH FACTOR-RECEPTOR MUTANT LACKING THE AUTOPHOSPHORYLATION SITES INDUCES PHOSPHORYLATION OF SHC PROTEIN AND SHC-GRB2 ASH ASSOCIATION AND RETAINS MITOGENIC ACTIVITY [J].
GOTOH, N ;
TOJO, A ;
MUROYA, K ;
HASHIMOTO, Y ;
HATTORI, S ;
NAKAMURA, S ;
TAKENAWA, T ;
YAZAKI, Y ;
SHIBUYA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :167-171
[8]  
HSU CYJ, 1990, CELL GROWTH DIFFER, V1, P191
[9]   OVEREXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN PANCREATIC-CANCER IS ASSOCIATED WITH CONCOMITANT INCREASES IN THE LEVELS OF EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA [J].
KORC, M ;
CHANDRASEKAR, B ;
YAMANAKA, Y ;
FRIESS, H ;
BUCHLER, M ;
BEGER, HG .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1352-1360
[10]  
KORC M, 1989, J BIOL CHEM, V264, P14990